USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Evoco Ltd.

USPTO PatentsView assignee record - 12 granted patents across 13 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C08G (MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS).

The verdict

According to USPTO PatentsView, Evoco ranks #22,551 of 50,000 tracked US assignees by granted-patent volume, with 12 patents across 13 technology areas.

#22,551
of 50,000 US assignees by volume
Top 15%
by Innovation Score (49.1/100)
19.9
avg claims per patent

USPTO PatentsView assignee plate

Corpus R22551 · Foreign Corporation #22,551 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 12 grants
  • MID-PACK #22,551/50,000
  • PHOTO-FINISH Ethypharm
  • CPC-FOCUS C08G · 13 areas
  • INNOV-PAR 49.1/100
  • CLAIMS-RICH 19.9 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • SPAN-YRS 2021–2025 · 5y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Ethypharm (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Evoco

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Evoco's Innovation Score is 49.1/100 (top 15% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Evoco's grants concentrate

Evoco Ltd. is a focused PatentsView assignee: 13 CPC subclasses with 91.7% of grants classified under C08G (MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS). Peak complete grant year is 2021 (3 grants) versus a trough of 2 in 2022. By volume, Evoco sits between Ethypharm and Exosect Limited.

Who files at Evoco's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Evoco holds 12 patents at rank #22,552, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Evoco

By rank, the assignees closest to #22,552 in granted patent volume.

Leaders in C08G (Macromolecular Compounds Obtained Otherwise THAN BY React…)

Other assignees with the most granted patents in Evoco's primary technology class.

Evoco's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 15% higher than 85% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). This entry sits in this band. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

1.522.533.5 20212022202320242025 2
USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table
Evoco Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2021 3 25.0%
2022 2 16.7%
2023 2 16.7%
2024 3 25.0%
2025partial year 2 16.7%

Which technologies does Evoco Ltd. patent most?

Top 13 of 13 technology areas

Where it ranks

Overall rank by patents

#22,551

of 50,000 tracked assignees

Innovation Score

49.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.